BIOMAT Database Logo BIOMAT Database Logo

Synthesis and topoisomerase I inhibitory properties of luotonin A analogues. 2004

Ali Cagir, and Brian M Eisenhauer, and Rong Gao, and Shannon J Thomas, and Sidney M Hecht
Department of Chemistry and Department of Biology, University of Virginia, Charlottesville, VA 22901, USA.

Luotonin A, a naturally occurring pyrroloquinazolinoquinoline alkaloid, has been previously demonstrated to be a topoisomerase I poison. A number of luotonin A derivatives have now been prepared through the condensation of anthranilic acid derivatives and 1,2-dihydropyrrolo[3,4-b]quinoline-3-one in the presence of phosphorus oxychloride. When dichloromethane was used as solvent the reaction proceeded to a single product. In contrast when the reaction was carried out in tetrahydrofuran or in phosphorus oxychloride, an additional isomeric product was obtained. The luotonin A analogues were evaluated for their ability to effect stabilization of the covalent binary complex formed between human topoisomerase I and DNA, and for cytotoxicity toward a yeast strain expressing the human topoisomerase I.

UI MeSH Term Description Entries
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D011809 Quinones Hydrocarbon rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004264 DNA Topoisomerases, Type I DNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix. DNA Nicking-Closing Protein,DNA Relaxing Enzyme,DNA Relaxing Protein,DNA Topoisomerase,DNA Topoisomerase I,DNA Topoisomerase III,DNA Topoisomerase III alpha,DNA Topoisomerase III beta,DNA Untwisting Enzyme,DNA Untwisting Protein,TOP3 Topoisomerase,TOP3alpha,TOPO IIIalpha,Topo III,Topoisomerase III,Topoisomerase III beta,Topoisomerase IIIalpha,Topoisomerase IIIbeta,DNA Nicking-Closing Proteins,DNA Relaxing Enzymes,DNA Type 1 Topoisomerase,DNA Untwisting Enzymes,DNA Untwisting Proteins,Topoisomerase I,Type I DNA Topoisomerase,III beta, Topoisomerase,III, DNA Topoisomerase,III, Topo,III, Topoisomerase,IIIalpha, TOPO,IIIalpha, Topoisomerase,IIIbeta, Topoisomerase,Topoisomerase III, DNA,Topoisomerase, TOP3,beta, Topoisomerase III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012441 Saccharomyces cerevisiae A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as "baker's" or "brewer's" yeast. The dried form is used as a dietary supplement. Baker's Yeast,Brewer's Yeast,Candida robusta,S. cerevisiae,Saccharomyces capensis,Saccharomyces italicus,Saccharomyces oviformis,Saccharomyces uvarum var. melibiosus,Yeast, Baker's,Yeast, Brewer's,Baker Yeast,S cerevisiae,Baker's Yeasts,Yeast, Baker
D012997 Solvents Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant & Hackh's Chemical Dictionary, 5th ed) Solvent
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D059004 Topoisomerase I Inhibitors Compounds that inhibit the activity of DNA TOPOISOMERASE I. DNA Topoisomerase I Inhibitor,DNA Topoisomerase III Inhibitor,DNA Topoisomerase III Inhibitors,DNA Type 1 Topoisomerase Inhibitor,DNA Type III Topoisomerase Inhibitor,DNA Type III Topoisomerase Inhibitors,Topoisomerase 1 Inhibitor,Topoisomerase 1 Inhibitors,Topoisomerase 3 Inhibitor,Topoisomerase 3 Inhibitors,Topoisomerase I Inhibitor,Topoisomerase III Inhibitor,Topoisomerase III Inhibitors,DNA Topoisomerase I Inhibitors,DNA Type 1 Topoisomerase Inhibitors,1 Inhibitor, Topoisomerase,3 Inhibitor, Topoisomerase,3 Inhibitors, Topoisomerase,I Inhibitor, Topoisomerase,III Inhibitor, Topoisomerase,III Inhibitors, Topoisomerase,Inhibitor, Topoisomerase 1,Inhibitor, Topoisomerase 3,Inhibitor, Topoisomerase I,Inhibitor, Topoisomerase III,Inhibitors, Topoisomerase 1,Inhibitors, Topoisomerase 3,Inhibitors, Topoisomerase I,Inhibitors, Topoisomerase III
D030781 Organisms, Genetically Modified Organisms whose GENOME has been changed by a GENETIC ENGINEERING technique. Genetically Modified Organisms,Organisms, Transgenic,Transgenic Organisms,GMO Organism,GMO Organisms,Genetically Engineered Organisms,Genetically Modified Organism,Modified Organism, Genetically,Organism, Genetically Modified,Organism, Transgenic,Organisms, Genetically Engineered

Related Publications

Ali Cagir, and Brian M Eisenhauer, and Rong Gao, and Shannon J Thomas, and Sidney M Hecht
Synthesis and Topoisomerase I inhibitory properties of klavuzon derivatives.
April 2017, Bioorganic chemistry,
Ali Cagir, and Brian M Eisenhauer, and Rong Gao, and Shannon J Thomas, and Sidney M Hecht
Total synthesis of luotonin A and 14-substituted analogues.
August 2007, Organic & biomolecular chemistry,
Ali Cagir, and Brian M Eisenhauer, and Rong Gao, and Shannon J Thomas, and Sidney M Hecht
One-pot synthesis of luotonin A and its analogues.
March 2011, Organic letters,
Ali Cagir, and Brian M Eisenhauer, and Rong Gao, and Shannon J Thomas, and Sidney M Hecht
Design, synthesis and antiproliferative activity of decarbonyl luotonin analogues.
September 2017, European journal of medicinal chemistry,
Ali Cagir, and Brian M Eisenhauer, and Rong Gao, and Shannon J Thomas, and Sidney M Hecht
D-Ring-Modified Analogues of Luotonin A with Reduced Planarity: Design, Synthesis, and Evaluation of Their Topoisomerase Inhibition-Associated Cytotoxicity.
January 2019, BioMed research international,
Ali Cagir, and Brian M Eisenhauer, and Rong Gao, and Shannon J Thomas, and Sidney M Hecht
Acylshikonin analogues: synthesis and inhibition of DNA topoisomerase-I.
March 1995, Journal of medicinal chemistry,
Ali Cagir, and Brian M Eisenhauer, and Rong Gao, and Shannon J Thomas, and Sidney M Hecht
Design, synthesis and antiproliferative evaluation of fluorenone analogs with DNA topoisomerase I inhibitory properties.
November 2013, Bioorganic & medicinal chemistry,
Ali Cagir, and Brian M Eisenhauer, and Rong Gao, and Shannon J Thomas, and Sidney M Hecht
Design and synthesis of lamellarin D analogues targeting topoisomerase I.
November 2009, The Journal of organic chemistry,
Ali Cagir, and Brian M Eisenhauer, and Rong Gao, and Shannon J Thomas, and Sidney M Hecht
Semi-synthesis, topoisomerase I and kinases inhibitory properties, and antiproliferative activities of new rebeccamycin derivatives.
November 2003, Bioorganic & medicinal chemistry,
Ali Cagir, and Brian M Eisenhauer, and Rong Gao, and Shannon J Thomas, and Sidney M Hecht
Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives.
June 2007, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!